Portfolio Update

Finsbury Worldwide Pharm Tst PLC
03 October 2006



                                                                  3 October 2006





                   FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
                                 (the 'Company')



                       QUARTERLY STATEMENT OF INVESTMENTS



In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:



  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                        Value of Investment at      % of Total
                                                                      30 September 2006     Portfolio  Assets

NOVARTIS CHF0.50 REGD                                                     30,988,217               9.13
GENENTECH INC COM STK USD0.02 NPV                                         21,450,413               6.32
WYETH COM USD0.333                                                        19,378,506               5.71
AMGEN COM USD0.0001                                                       18,778,163               5.53
ELI LILLY & COMPANY COM USD NPV                                           17,542,895               5.17


  • The ten largest investments held by the Company comprise the following:



Company Name                                                         Value of Investment at      % of Total
                                                                   30 September 2006          Portfolio Assets

NOVARTIS CHF0.50 REGD                                                      30,988,217               9.13
GENENTECH INC COM STK USD0.02 NPV                                          21,450,413               6.32
WYETH COM USD0.333                                                         19,378,506               5.71
AMGEN COM USD0.0001                                                        18,778,163               5.53
ELI LILLY & COMPANY COM USD NPV                                            17,542,895               5.17
JOHNSON & JOHNSON COM USD1                                                 16,895,977               4.98
PFIZER COM USD0.05                                                         15,814,503               4.66
TAKEDA PHARAMACEUTICAL CO NPV                                              12,962,301               3.82
GENZYME CORP GENERAL DIVISION COM USD0.01                                  12,701,507               3.74
GEN-PROBE INC USD0.0001                                                    12,018,737               3.54







                                    - ENDS -



For further information please contact:
Tracey Lago, Senior Company Secretary
Close Finsbury Asset Management Limited
Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange